TAVI Hotline 2

Watch later Remove
Session comprising selected PCR London Valves 2024 Late-Breaking Trials submissions
TAVI
Hot line / Late-Breaking Trials
Room 4

Facilitators: Andreas Baumbach, Helge Möllmann

Discussants: Carla Romina Agatiello, Tom Cahill, Christian Juhl Terkelsen, Jian’An Wang

Five-year outcomes after AVR in low-risk patients stratified by annulus size

Mahesh Madhavan

Discussion and audience interaction
Valve performance between the SAPIEN 3 Ultra RESILIA and Evolut FX in a small aortic annulus

Hirofumi Hioki

Discussion and audience interaction
Long-term clinical impact of paravalvular leak following TAVI

Cristina Aurigemma

Discussion and audience interaction
Clinical impact of frame underexpansion using a self-expanding transcatheter heart valve

Won-Keun Kim

Discussion and audience interaction
Clinical updates on the first dedicated leaflet splitting device prior TAVI

Danny Dvir

Discussion and audience interaction

Suggested videos

5:56
PCR Roundtables
PCR Roundtable - TRISCEND II Pivotal Trial How will TTVR impact the treatment of patients with tricuspid regurgitation?
Watch later Remove
PCR Highlights - Top Late-Breaking Trial at PCR London Valves 2024 - Compare TAVI
Watch later Remove
Zero-contrast TAVI while using a novel full-body embolic protection filter
Watch later Remove
From index procedure to re-valving with a novel self-expanding valve
Watch later Remove
Innovation for transcatheter tricuspid interventions
Watch later Remove
PCR Perspectives - What do we know about bleeding risk and antithrombotic management after tricuspid valve interventions?
Watch later Remove
PCR Perspectives - How to safely discharge your patient post TAVI?
Watch later Remove